Клеточные и молекулярные механизмы патогенеза иммуновоспалительных ревматических заболеваний

60. Gross H., Hennard C., Masouris I., Cassel C., Barth S. Binding of the heterogeneous ribonucleoprotein K (hnRNP K) to the Epstein-Barr virus nuclear antigen 2 (EBNA2) enhances viral LMP2A expression. 2012; PLOS ONE 7:e42106.

61. Gupta A. K., Joshi M. B., Philippova M., Erne P., Hasler P., Hahn S., Resink T. J. Activated endothelial cells induce neutrophil extracellular traps and are susceptible to NETosis-mediated cell death. FEBS Lett., 2010; 584, pp.3193–3197. doi: 10.1016/j.febslet.2010.06.006.

62. Hase K., Tani K., Shimizu T, Ohmoto Y., Matsushima K., Sone S. Increased CCR4 expression in active systemic Lupus erythematosus. J. Leukocyte Biol., 2001, Vol. 70, pp. 749.

63. Helming L., Gordon S. Molecular mediators of macrophage fusion. Trends Cell Biol., 2009, Vol. 19, no.5, pp.514–522. doi: 10.1016/j.tcb.2009.07.005.

64. Hernandez-Molina G., Michel-Peregrina M., Hernandez-Ramirez D. F., Sanchez-Guerrero J., Llorente L. Chemokine saliva levels in patients with primary Sjogren’s syndrome, associated Sjogren’s syndrome, pre-clinical Sjogren’s syndrome and systemic autoimmune diseases. Rheumatology, 2011, Vol. 50, no.7, pp.1288–1292. doi: 10.1093/rheumatology/ker019.

65. Herrmann M., Voll R. E., Zoller O. M., Hagenhofer M., Ponner B. B., Kalden J. R. Impaired phagocytosis of apoptotic cell material by monocyte-derived macrophages from patients with systemic lupus erythematosus. Arthritis Rheum.,1998, Vol.41, no.7, pp.:1241–1250. doi: 10.1002/1529- 0131(199807)41:7<1241::AID-ART15>3.0.CO;2-H.

66. Higashi-Kuwata N., Makino T., Inoue Y., Takeya M., Ihn H. Alternatively activated macrophages (M2 macrophages) in the skin of patient with localized scleroderma. Exp Dermatol., 2009, Vol. 18, no.8, pp.727–729. doi: 10.1111/j.1600–0625.2008.00828.x.

67. Higgs B. W., Liu Z., White B., Zhu W., White W., Morehouse C….Yao Y.. Patients with systemic lupus erythematosus, myositis, rheumatoid arthritis and scleroderma share activation of a common type I interferon pathway. Ann. Rheum. Dis., 2011, Vol.70, no. 11, pp. 2029–2036. doi: 10.1136/ard.2011.150326.

68. HjelmstroEm P. Lymphoid neogenesis – de novo formation of lymphoid tissue in chronic inflammation through expression of homing chemokines. J. Leuk. Biol., 2001, Vol.69, pp.331–339. doi: 10.1097/BOR.0b013e32835fd8eb.

69. HjelmstroEm P., Fjell J., Nakagawa T., Sacca R., Cuff C. A., Ruddle N. H. Lymphoid tissue homing chemokines are expressed in chronic inflammation. Am. J. Pathol., 2000, Vol.156, no.4, pp.1133–1138. doi: 10.1016/S0002–9440(10)64981–4.

70. Horikawa S., Ishii Y., Hamashima T., Yamamoto S., Mori H., Fujimori T….Sasahara M.. PDGFR? plays a crucial role in connective tissue remodeling. Scientific RepoRts., 2015; 5:17948. doi: 10.1038/srep17948.

71. Humby F., Bombardieri M., Manzo A., Kelly S., Blades M. C., Kirkham B. Ectopic lymphoid structures support ongoing production of class- switched autoantibodies in rheumatoid synovium. PLoS Med. 2009; 6:e1. doi: 10.1371/journal.pmed.0060001.

72. Jara L. J., Medina. G., Saavedra M. A. Autoimmune manifestations of infections. Curr Opin. Rheumatol. 2018, Vol. 30, no.46, pp.373–379. DOI:10.1097/BOR.0000000000000505.

73. Jego G., Palucka A. K., Blanck J. P., Chalouni C., Pascual V., Banchereau J. Plasmacytoid dendritic cells induce plasma cell differentiation through type I interferon and interleukin 6. Immunity, 2003, Vol. 19, no.2, pp.225–234. doi: 10.1016/s1074–7613(03)00208–5.

74. Jenkins M. K., Khoruts A., Ingulli E., Mueller D. L., McSorley S. J., Reinhardt R., Itano A., Pape A. In vivo activation of antigen- specific CD4 T cells. Annu. Rev. Immunol., 2001, Vol.19, pp. 23–45. doi: 10.1146/annurev.immunol.19.1.23.

75. Jesus A. A., Goldbach-Mansky R. IL-1 blockade in autoinflammatory syndromes. Annu. Rev. Med., 2014, Vol. 65, pp.223–244. doi: 10.1146/annurev-med-061512–150641.

76. Jorch S., Kubes P. An emerging role for neutrophil extracellular traps in noninfectious disease. NATURE MEDICINE, 2017, Vol. 23, no.3, pp. 279–287. doi:10.1038/nm.4294.

77. Jurewicz М. М., Stern. L. G. Class II MHC antigen processing in immune tolerance and inflammation. Immunogenetics, 2019, Vol. 71, no.3, pp.171–187. doi:10.1007/s00251–018–1095-x.